Uscom Receives $0.5M R&D Cash Refund
Filed with ASX · · 2 pages · English
SYDNEY, Australia, Monday 20 March 2017: Uscom Limited (ASX code: UCM) (the Company or Uscom) has received $0.496M from the Australian Tax Office under the Federal Government Research and Development (R&D) Tax Incentive Program related to R&D expenditure in the 2016 tax year. The Federal Government R&D program provides for the refund of 45% of eligible research and development expenditure during t
Earlier from Uscom
- New BP Plus Patent
- Uscom BPplus Detects New Evidence of Cardiovascular Disease
- Uscom ends 2016 with record manufacturing
- Uscom Awarded Euro Grant for Lung Cancer Diagnostic
- CE Mark for New Uscom Asthma and COPD Devices
Later from Uscom
- China BP Plus and SpiroSonic Regulatory Submissions
- New USCOM Evidence for Preeclampsia
- New Uscom Euro Grant for Pulmonary Research
- Uscom Achieves First Cash Flow Positive Quarter
- Uscom Achieves First Cash Flow Positive Quarter Appendix 4C
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom